Hosted By
In this special Cambridge Tech Week podcast episode we chat to Umaima Ahmad, CEO and co-founder of 52North, a multi-award winning med-tech company focused on reinventing the healthcare journey, starting by transforming cancer care with Neutrocheck®. She shares lessons learned from the early days of Neutrocheck to the company recently being the first ever venture investment of Macmillan Cancer Support.
Hear how Umaima moved from a successful career as a finance lawyer into the world of entrepreneurship and healthcare, via her role in business development at AstraZeneca. She tells us about how the idea came about, the importance of good hires and provides some tips on securing early investors.
We recently spoke to Cambridge Angels, Simon Thorpe and Phil O'Donovan about what they do, what makes a good investment and why Cambridge is...
This episode is the next in our Business Basics series and focuses on communication for Start-ups. Simon Hall, a journalist of 25 years' experience,...
Rosemary Francis is an expert on computer architecture, high-performance computing and analytics. She founded, and spent ten years building, Ellexus, which was subsequently acquired...
